Impact of Diabetes and Insulin Use on Prognosis in Patients With Resected Pancreatic Cancer: An Ancillary Analysis of NRG Oncology RTOG 9704
Year: 2020
Type: article
Authors: Danielle S. Bitterman, Kathryn A. Winter, Theodore S. Hong, Charles S. Fuchs, William F. Regine, Ross A. Abrams, Howard Safran, John P. Hoffman, Al B. Benson, Timothy Kasunic, Mary Mulcahy, James F. Strauss, Thomas DiPetrillo, Philip J. Stella, Yuhchyau Chen, John P. Plastaras, Christopher H. Crane
Institutions: Harvard University, NRG Oncology, Massachusetts General Hospital, Yale Cancer Center, Yale University, University of Maryland, Baltimore, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Rush University Medical Center, Rhode Island Hospital, Fox Chase Cancer Center, Northwestern University, Toledo Clinic Cancer Center, Texas Health Dallas, Lifespan, Michigan Cancer Research Consortium, University of Rochester, Abramson Cancer Center, University of Pennsylvania, Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: National Cancer Institute
Awards: ECOG-ACRIN Network Group Operations Center, Network Lead Academic Participating Site: Memorial Sloan Kettering Cancer Center, SWOG Network Group Operations Center of the NCTN, NRG Oncology Network Group Operations Center, Rochester Network Lead Academic Participating Site, Cancer Center Support Grant, NRG Oncology - Statistical and Data Management Center
OpenAlex ID: W3080308307